SOGROYA Trademark

Trademark Overview

On Friday, May 24, 2019, a trademark application was filed for SOGROYA with the United States Patent and Trademark Office. The USPTO has given the SOGROYA trademark a serial number of 79262550. The federal status of this trademark filing is REGISTERED as of Tuesday, December 17, 2019. This trademark is owned by Novo Nordisk Health Care AG. The SOGROYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hormonal disorders
sogroya

General Information

Serial Number79262550
Word MarkSOGROYA
Filing DateFriday, May 24, 2019
Status700 - REGISTERED
Status DateTuesday, December 17, 2019
Registration Number5934737
Registration DateTuesday, December 17, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hormonal disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Thursday, July 11, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2019ASSIGNED TO EXAMINER
Friday, July 19, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, July 24, 2019NON-FINAL ACTION WRITTEN
Thursday, July 25, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, July 31, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 7, 2019ASSIGNED TO LIE
Thursday, August 15, 2019ASSIGNED TO LIE
Friday, August 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 20, 2019REFUSAL PROCESSED BY MPU
Tuesday, August 20, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 6, 2019REFUSAL PROCESSED BY IB
Wednesday, September 11, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 18, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 18, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, October 1, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, October 5, 2019NOTIFICATION PROCESSED BY IB
Tuesday, December 17, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 28, 2020FINAL DISPOSITION PROCESSED
Saturday, March 28, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 17, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, November 10, 2025TEAS SECTION 71 RECEIVED

Related Keywords

sogroya disorders hormonal treatment preparations pharmaceutical